Additional data has been published that supports the effectiveness of Anavex Life Sciences Corp.'s (Nasdaq: AVXL) ANAVEX 3-71 in treating Alzheimer's disease. The stock price leaped $1.83 to $7.83.
More positive data on Anavex Life Sciences' ANAVEX 3-71
November 30, 2015 at 12:35 PM EST
